MS Clinical Trials Group

Vancouver, British Columbia V6T 1Z3

0 studies enrolling now · 2 studies all time

What they study most

NMO Spectrum Disorder (NMOSD), Neuromyelitis Optica (NMO), Neuromyelitis Optica Spectrum Disorder

Studies at this site

• A Study to Evaluate the Safety and Efficacy of Satralizumab in Participants With Neuromyelitis Optica Spectrum Disorder (NMOSD) — Completed
• Efficacy and Safety Study of Satralizumab (SA237) as Monotherapy to Treat Participants With Neuromyelitis Optica (NMO) and Neuromyelitis Optica Spectrum Disorder (NMOSD) — Completed